Intrathecal Administration of Baclofen (ITB) to Cerebral Palsy Patients With Therapy-Resistant Spasticity

• Status: Completed
• Trial end date: 2006-08-01
• Target enrollment: 0
• Participant gender: All

Summary

Evaluation of the effect of intrathecal administration of Baclofen on spasticity of cerebral palsy patients, by means of standardized and internationally accepted scales

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: University Hospital, Ghent
• Treatments: Baclofen

Criteria

Inclusion Criteria:

• CP patients with therapy-resistent spasticity

• Patients with sufficient body weight in relation to the volume

• Oral medication has failed: insufficient effect or too many side-effects

• The patient and family understand the objectives of the treatment and accept those objectives

• Informed Consent

Exclusion Criteria:

• Contra-indications for surgery (e.g. infection)

• Hypersensitivity to oral Baclofen